Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Stereotaxis Inc. (STXS : AMEX)
 
 • Company Description   
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.

Number of Employees: 130

 
 • Price / Volume Information   
Yesterday's Closing Price: $1.79 Daily Weekly Monthly
20 Day Moving Average: 567,458 shares
Shares Outstanding: 74.66 (millions)
Market Capitalization: $133.64 (millions)
Beta: 1.74
52 Week High: $10.30
52 Week Low: $1.72
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -38.06% -30.25%
12 Week -62.32% -58.57%
Year To Date -71.13% -65.51%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
710 North Tucker Boulevard Suite 110
-
ST.LOUIS,MO 63101
USA
ph: 314-678-6100
fax: 314-678-6159
investors@stereotaxis.com http://www.stereotaxis.com
 
 • General Corporate Information   
Officers
David L. Fischel - Chairman of the Board of Directors and Chief Execu
Kimberly R. Peery - Chief Financial Officer
David W. Benfer - Director
Nathan Fischel - Director
Myriam J. Curet - Director

Peer Information
Stereotaxis Inc. (ABMD)
Stereotaxis Inc. (DMDS)
Stereotaxis Inc. (CPWY.)
Stereotaxis Inc. (EQUR)
Stereotaxis Inc. (ECIA)
Stereotaxis Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 85916J409
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 74.66
Most Recent Split Date: 7.00 (0.10:1)
Beta: 1.74
Market Capitalization: $133.64 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.06 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.20 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.14
Price/Cash Flow: -
Price / Sales: 4.00
EPS Growth
vs. Year Ago Period: -200.00%
vs. Previous Quarter: -20.00%
Sales Growth
vs. Year Ago Period: -18.39%
vs. Previous Quarter: -14.60%
ROE
03/31/22 - -38.69
12/31/21 - -30.70
09/30/21 - -24.33
ROA
03/31/22 - -22.33
12/31/21 - -17.93
09/30/21 - -14.63
Current Ratio
03/31/22 - 4.10
12/31/21 - 3.87
09/30/21 - 3.86
Quick Ratio
03/31/22 - 3.68
12/31/21 - 3.54
09/30/21 - 3.58
Operating Margin
03/31/22 - -39.69
12/31/21 - -30.60
09/30/21 - -25.42
Net Margin
03/31/22 - -39.69
12/31/21 - -30.60
09/30/21 - -25.42
Pre-Tax Margin
03/31/22 - -39.69
12/31/21 - -30.60
09/30/21 - -25.42
Book Value
03/31/22 - 0.43
12/31/21 - 0.45
09/30/21 - 0.46
Inventory Turnover
03/31/22 - 2.61
12/31/21 - 2.95
09/30/21 - 2.99
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©